SCHEMBL2228093

SCHEMBL2228093

COc1ccc(CN2CCC(n3cnc4cnc5c(ccn5S(=O)(=O)c5ccccc5)c43)CC2=O)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
JAK1 P23458 1/20 0.40
PKM P14618 1/20 0.39
BTK Q06187 1/20 0.38
TP53 P04637 1/20 0.37
HTR6 P50406 6/20 0.36
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 2/20 0.34
USP2 O75604 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
MAPK10 P53779 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PDE9A O76083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276884 0.86 POLB (0.40) POLBKDM4EALDH1A1JAK1PKM
SCHEMBL2223933 0.85 JAK1 (0.47) JAK1HTR6
SCHEMBL2282644 0.79 KDM4E (0.41) POLBKDM4EALDH1A1BTKTP53
SCHEMBL2272155 0.77 KDM4E (0.39) POLBKDM4EALDH1A1BTKTP53
SCHEMBL2225853 0.76 ALDH1A1 (0.39) POLBKDM4EALDH1A1TP53HTR6
SCHEMBL2276333 0.75 JAK1 (0.52) JAK1PKMHTR6
SCHEMBL2275475 0.74 JAK1 (0.43) JAK1HTR6
SCHEMBL2282176 0.73 JAK1 (0.59) JAK1HTR6
SCHEMBL2279026 0.73 JAK1 (0.52) KDM4EALDH1A1JAK1HTR6KMT2A
SCHEMBL2224840 0.72 HTR6 (0.49) JAK1HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523957-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2012-11-21 EP disclosed
WO-2011086053-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed